These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

973 related items for PubMed ID: 6246138

  • 1. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME, Sheehan KL, Casper RF, Yen SS.
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [Abstract] [Full Text] [Related]

  • 2. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus.
    Djursing H, Hagen C, Nyholm HC, Carstensen L, Andersen AN.
    J Clin Endocrinol Metab; 1983 May; 56(5):1016-21. PubMed ID: 6403566
    [Abstract] [Full Text] [Related]

  • 3. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH, Fleischer N, Lev-Gur M, Freeman RG.
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [Abstract] [Full Text] [Related]

  • 4. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
    Quigley ME, Judd SJ, Gilliland GB, Yen SS.
    J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
    [Abstract] [Full Text] [Related]

  • 5. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I, Ambrosi F, Giammartino C, Fedeli L, Mannarelli C, Filipponi P.
    Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
    [Abstract] [Full Text] [Related]

  • 6. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
    Healy DL, Pepperell RJ, Stockdale J, Bremner WJ, Burger HG.
    J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
    [Abstract] [Full Text] [Related]

  • 7. Factors influencing the dynamics of gonadotropin response following bolus infusion of luteinizing hormone-releasing factor in women with menstrual abnormalities.
    Cantor B, Kalra PS, Buhi WC, Birk SA, Spellacy WN.
    Fertil Steril; 1977 May; 28(5):526-30. PubMed ID: 323072
    [Abstract] [Full Text] [Related]

  • 8. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI, Winter JS, Faiman C.
    Am J Obstet Gynecol; 1977 Nov 01; 129(5):557-64. PubMed ID: 910845
    [Abstract] [Full Text] [Related]

  • 9. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea.
    Berga SL, Mortola JF, Girton L, Suh B, Laughlin G, Pham P, Yen SS.
    J Clin Endocrinol Metab; 1989 Feb 01; 68(2):301-8. PubMed ID: 2493024
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
    Tyson JE, Khojandi M, Huth J, Smith B, Thomas P.
    Am J Obstet Gynecol; 1975 Feb 01; 121(3):375-9. PubMed ID: 1115151
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB, Nippoldt TB, Kletter GB, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1991 Nov 01; 73(5):1099-105. PubMed ID: 1939525
    [Abstract] [Full Text] [Related]

  • 16. Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation.
    Perkins RB, Hall JE, Martin KA.
    J Clin Endocrinol Metab; 1999 Jun 01; 84(6):1905-11. PubMed ID: 10372685
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Opioid regulation of luteinizing hormone in amenorrheic patients after therapy for induction of ovulation.
    Nappi C, Petraglia F, Di Meo G, Minutolo M, Genazzani AR, Montemagno U.
    Fertil Steril; 1987 Apr 01; 47(4):579-83. PubMed ID: 3032691
    [Abstract] [Full Text] [Related]

  • 19. Hypothalamic function in amenorrheic runners.
    Dixon G, Eurman P, Stern BE, Schwartz B, Rebar RW.
    Fertil Steril; 1984 Sep 01; 42(3):377-83. PubMed ID: 6432587
    [Abstract] [Full Text] [Related]

  • 20. Acceleration of luteinizing hormone pulse frequency in functional hypothalamic amenorrhea by dopaminergic blockade.
    Berga SL, Loucks AB, Rossmanith WG, Kettel LM, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1991 Jan 01; 72(1):151-6. PubMed ID: 1986014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.